Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) in patients with refractory germ cell tumors.
Chun
H
H
Bosl
G J
GJ
Golbey
R B
RB
D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D009944:Organoplatinum Compounds; C021967:carboxyphthalato-1,2-diaminocyclohexaneplatinum